Commentary: Not Aricept but Donepezil Should not Permit for Lewy Body Disease without Proper Clinical Trials
Received Date: Aug 22, 2018 / Accepted Date: Aug 24, 2018 / Published Date: Aug 31, 2018
Keywords: Alzheimer’s Disease (AD); Aricept (original medicine of Donepezil); Effective range; Lewy Body Disease (LBD)
Citation: Hori K, Sodenaga M (2018) Commentary: Not Aricept but Donepezil Should not Permit for Lewy Body Disease without Proper Clinical Trials. J Alzheimers Dis Parkinsonism 8: 447. Doi: 10.4172/2161-0460.1000447
Copyright: © 2018 Hori K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 3182
- [From(publication date): 0-2018 - Nov 24, 2024]
- Breakdown by view type
- HTML page views: 2553
- PDF downloads: 629
